Decision: Favourable
Study Title:
A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclerosis ADORE (ALS Deceleration with ORal Edaravone) study
NREC Code:
21-NREC-CT-020
Decision:
Favourable
Meeting Date:
21/07/2021
Study Type:
CT application
Principal Investigator:
Prof Orla Hardiman
PI Institution:
Beaumont Hospital
Sponsor:
Ferrer International S.A.